News

1. DM Clinical Research Marks 20 Years of Advancing Clinical Research

   20 Years of Impact: Expanding Patient Access and Accelerating Innovation

2. Creative Biolabs Integrates Microfluidics and Electrochemical Biosensors to Accelerate Next-Generation POCT Diagnostics

   Creative Biolabs has expanded its development platform by integrating advanced chip-based fluidics with electronic detection architectures.

3. The Power of Evidence-Led Strategy: Stelios Tzellos, PhD, on Why Scientific Thinking Should Drive Oncology Market Planning

   Stelios Tzellos explains why scientific understanding, not data alone, leads to more accurate pharmaceutical strategy.

4. Next-Generation Precision Obesity Models: Closing the Translational Gap in Anti-Obesity Drug Development

   Moving Beyond the Scale—How Precision-Engineered Models Are Redefining Preclinical Obesity Research

5. Creative Enzymes Launches AI-Integrated Biocatalysis Platform to Accelerate Enzyme Development

   AI-Powered Biocatalysis: Closing the Gap Between Discovery and Industrial Scale

6. Amerigo Scientific Releases High-Quality iPSC-Derived Cells to Accelerate Biomedical Research and Cell Therapy Development

   Amerigo Scientific recently released high-purity, premium-quality induced pluripotent stem cell (iPSC)-derived cells and engineered reporter iPSC-derived cells.

7. Ace Therapeutics Announces Comprehensive Preclinical Analgesic Drug Development Services with Full-Spectrum Pain Research Platform

   Ace Therapeutics announces its robust end-to-end solutions dedicated to advancing pain therapeutic development, featuring diverse validated in vivo pain models for drug testing.

8. Creative Diagnostics Launches Hantavirus Research Reagents and Products to Accelerate Global Diagnostic and Vaccine Research

   Creative Diagnostics announces Hantavirus Research Reagents and Products to support hantavirus research and diagnostic assay development.

9. Protheragen Announces Tailored Novel Drug Delivery System Services for Pharmaceutical and Biomedical Clients

   Protheragen rolled out its integrated solutions covering hydrogel drug delivery systems, microneedle development, and lyophilized flash release formulations.

10. Ace Therapeutics Launches Full-Scale Preclinical Hematology CRO Services with Expanded In Vivo Hematologic Disease Models

    Ace Therapeutics announces its comprehensive suite of integrated preclinical hematology CRO services designed to accelerate the discovery and regulatory advancement of novel therapeutics for a broad spectrum of hematologic diseases.